Works by Desai, Sanjal H.

Results: 7

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
By:
- Desai, Sanjal H.;
- Pederson, Levi;
- LaPlant, Betsy;
- Mwangi, Raphael;
- Maurer, Matthew;
- Young, Jason R.;
- Macon, William R.;
- King, Rebecca L.;
- Wang, Yucai;
- Cerhan, James R.;
- Feldman, Andrew;
- Inwards, David J.;
- Micallef, Ivana;
- Johnston, Patrick;
- Porrata, Luis F.;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
By:
- Desai, Sanjal H.;
- LaPlant, Betsy;
- Macon, William R.;
- King, Rebecca L.;
- Wang, Yucai;
- Inwards, David J.;
- Micallef, Ivana;
- Johnston, Patrick B.;
- Porrata, Luis F.;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.
Published in:
2021
By:
- Desai, Sanjal H.;
- Baez-Sosa, Valentina;
- Hameed, Rumaisa;
- Al-Shbool, Ghassan;
- Fernandez, Stephen;
- Vakiti, Anusha;
- Stingo, Facundo;
- Adhikari, Tripti;
- Paku, Emily;
- Malkovska, Vera;
- Fishbein, Dawn
Publication type:
journal article
Management of post‐transplant lymphoproliferative disorders.
Published in:
British Journal of Haematology, 2018, v. 182, n. 3, p. 330, doi. 10.1111/bjh.15263
By:
- DeStefano, Christin B.;
- Desai, Sanjal H.;
- Shenoy, Aarthi G.;
- Catlett, Joseph P.
Publication type:
Article
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, n. 1, p. 39, doi. 10.1002/hon.3098
By:
- Desai, Sanjal H.;
- Mwangi, Raphael;
- Smith, Alexandra N.;
- Maurer, Matthew J.;
- Farooq, Umar;
- King, Rebecca L.;
- Cerhan, James R.;
- Feldman, Andrew L.;
- Habermann, Thomas M.;
- Thompson, Carrie A.;
- Wang, Yucai;
- Ansell, Stephen M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Lymphoma survivors have an increased long-term risk of chronic kidney disease.
Published in:
Leukemia & Lymphoma, 2020, v. 61, n. 12, p. 2923, doi. 10.1080/10428194.2020.1786555
By:
- Desai, Sanjal H.;
- Al-shbool, Ghassan;
- Desale, Sameer;
- Veis, Judith;
- Malkovska, Vera
Publication type:
Article
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma.
Published in:
American Journal of Hematology, 2023, v. 98, n. 3, p. 464, doi. 10.1002/ajh.26827
By:
- Desai, Sanjal H.;
- Spinner, Michael A.;
- David, Kevin;
- Bachanova, Veronika;
- Goyal, Gaurav;
- Kahl, Brad;
- Dorritie, Kathleen;
- Azzi, Jacques;
- Kenkre, Vaishalee P.;
- Arai, Sally;
- Chang, Cheryl;
- Fusco, Brendon;
- Sumransub, Nuttavut;
- Hatic, Haris;
- Saba, Raya;
- Ibrahim, Uroosa;
- Harris, Elyse I.;
- Shah, Harsh;
- Murphy, Jacob;
- Ansell, Stephen
Publication type:
Article

Works by Desai, Sanjal H.

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.

Management of post‐transplant lymphoproliferative disorders.

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.

Lymphoma survivors have an increased long-term risk of chronic kidney disease.

Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma.